Anti-human FceR2 / CD23 (Lumiliximab Biosimilar) Beta chemokine receptor-like 1 Binding of SCF by the

Binding of SCF by the c-Kit receptor leads to homodimerization of the receptor and the activation of signalling pathways such as PI-3

: IHC0181R

The positive control slide provided in the kit allows you to be sure that the experimental set-up is working properly

Number Component 50T Concentration Storage 1 PBS Buffer (powder) 2L x 2 20x RT 2 Antigen Retrieval Buffer 20ml 100x 2-8°C 3 Endogenous Peroxidase Blocking Buffer 3ml RTU 2-8°C 4 Blocking Buffer 3ml RTU 2-8°C 5 Primary Antibody (Human Integrin alpha 2 Recombinant Rabbit mAb) 6ml RTU 2-8°C 6 Secondary Antibody (Goat Anti-Rabbit IgG H&L / HRP) 6ml RTU 2-8°C 7 Chromogen Component A 0

Anti-human FceR2 / CD23 (Lumiliximab Biosimilar) Beta chemokine receptor-like 1 Binding of SCF by theApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human Target Target Name FceR2 CD23 Target Uniprot P06734 Overview Catalog# BIO0588SM Product Name Anti human FceR2 CD23 (Lumiliximab Biosimilar) Specifications Conjugation None Clone# Lumiliximab Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower. Reconstitution Dissolve with sterile ddH2O